Cardiometabolic Polygenic Risk Scores and Osteoarthritis Outcomes: A Mendelian Randomization Study Using Data From the Malmö Diet and Cancer Study and the UK Biobank.

Abstract

OBJECTIVE:

To investigate the causal role of cardiometabolic risk factors in osteoarthritis (OA) using associated genetic variants.

METHODS:

We studied 27,691 adults from the Malmö Diet and Cancer Study (MDCS) and replicated novel findings among 376,435 adults from the UK Biobank. Trait-specific polygenic risk scores for low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels, triglyceride levels, body mass index (BMI), fasting plasma glucose (FPG) levels, and systolic blood pressure (BP) were used to test the associations of genetically predicted elevations in each trait with incident OA diagnosis (n = 3,559), OA joint replacement (n = 2,780), or both (total OA; n = 4,226) in Mendelian randomization (MR) analyses in the MDCS, and with self-reported and/or hospital-diagnosed OA (n = 65,213) in the UK Biobank. Multivariable MR, MR-Egger, and weighted median MR were used to adjust for potential pleiotropic biases.

RESULTS:

In the MDCS, genetically predicted elevation in LDL cholesterol level was associated with a lower risk of OA diagnosis (odds ratio [OR] 0.83 [95% confidence interval (95% CI) 0.73-0.95] per 1SD increase) and total OA (OR 0.87 [95% CI 0.78-0.98]), which was supported by multivariable MR for OA diagnosis (OR 0.84 [95% CI 0.75-0.95]) and total OA (0.87 [95% CI 0.78-0.97]), and by conventional 2-sample MR for OA diagnosis (OR 0.86 [95% CI 0.75-0.98]). MR-Egger indicated no pleiotropic bias. Genetically predicted elevation in BMI was associated with an increased risk of OA diagnosis (OR 1.65 [95% CI 1.14-2.41]), while MR-Egger indicated pleiotropic bias and a larger association with OA diagnosis (OR 3.25 [1.26-8.39]), OA joint replacement (OR 3.81 [95% CI 1.39-10.4]), and total OA (OR 3.41 [95% CI 1.43-8.15]). No associations were observed between genetically predicted HDL cholesterol level, triglyceride level, FPG level, or systolic BP and OA outcomes. The associations with LDL cholesterol levels were replicated in the UK Biobank (OR 0.95 [95% CI 0.93-0.98]).

CONCLUSION:

Our MR study provides evidence of a causal role of lower LDL cholesterol level and higher BMI in OA.

• Authors: George Hindy, Kristina E Åkesson, Olle Melander, Krishna G Aragam, Mary E Haas, Peter M Nilsson, Umesh T Kadam, Marju Orho-Melander
• Journal: Arthritis & rheumatology (Hoboken, N.J.) (Arthritis Rheumatol) Vol. 71 Issue 6 Pg. 925-934 (06 2019) ISSN: 2326-5205 [Electronic] United States
• PMID: 30615301 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2019 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.

Chemical References

• Blood Glucose
• Cholesterol, HDL
• Cholesterol, LDL
• Triglycerides

Topics

• Aged
• Arthroplasty, Replacement (statistics & numerical data)
• Blood Glucose (metabolism)
• Blood Pressure (genetics)
• Body Mass Index
• Cardiovascular Diseases (epidemiology, genetics, metabolism)
• Cholesterol, HDL (metabolism)
• Cholesterol, LDL (metabolism)
• Dyslipidemias (epidemiology, genetics, metabolism)
• Fasting (metabolism)
• Female
• Humans
• Incidence
• Male
• Mendelian Randomization Analysis
• Metabolic Syndrome (epidemiology, genetics, metabolism)
• Middle Aged
• Multifactorial Inheritance
• Osteoarthritis (epidemiology, genetics, metabolism, surgery)
• Overweight (epidemiology, genetics)
• Risk
• Sweden (epidemiology)
• Triglycerides (metabolism)
• United Kingdom (epidemiology)